Life360 (LIF) director sells shares after exercising stock options

Rhea-AI Filing Summary

Life360, Inc. director Chris Hulls reported an option exercise and related share sale. He exercised stock options for 27,000 shares of common stock at an exercise price of $8.19 per share, then sold 15,133 shares of common stock at a weighted average price of $39.43 per share.

Following these transactions, Hulls directly holds 334,319 shares of common stock and also reports indirect holdings through 2023 irrevocable trusts. The filing notes that the sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 16, 2025, and that 108,371 restricted stock units are included in his reported holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hulls Chris

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CALIFORNIA 94403

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/19/2026		M(1)		27,000	A	$8.19	349,452(2)(3)	D
Common Stock	03/19/2026		S(1)		15,133	D	$39.43(4)	334,319(2)(3)	D
Common Stock								195,312(5)	I	Held by the Robin Hulls 2023 Irrevocable Trust
Common Stock								195,312(5)	I	Held by the Rose Hulls 2023 Irrevocable Trust
Common Stock								195,312(5)	I	Held by the Mckenzie Hulls 2023 Irrevocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.19	03/19/2026		M(1)			27,000	(6)	05/20/2028	Common stock	27,000	$0	206,801	D

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

2. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

3. Includes 108,371 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

4. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $39.23 to $39.71, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

5. Represents shares of the Issuer's common stock underlying 585,938 CDIs.

6. The stock option is fully vested and exercisable.

Remarks:

	/s/ Jay Sood, Attorney-in-Fact	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Life360 (LIF) director Chris Hulls report on this Form 4?

Chris Hulls reported exercising stock options and selling shares of Life360 common stock. He exercised options for 27,000 shares at $8.19 per share and sold 15,133 shares at a weighted average price of $39.43 per share under a Rule 10b5-1 plan.

How many Life360 (LIF) shares did Chris Hulls sell and at what price?

Chris Hulls sold 15,133 shares of Life360 common stock. The shares were sold at a weighted average price of $39.43 per share, with individual sale prices ranging from $39.23 to $39.71, according to the Form 4 disclosure and related footnote.

Was Chris Hulls’ Life360 (LIF) share sale made under a Rule 10b5-1 trading plan?

Yes, the Form 4 states the transaction was effected under a Rule 10b5-1 trading plan. The plan was adopted on December 16, 2025, when Hulls was not aware of material nonpublic information, and it provides for automatic sales based on predetermined criteria.

How many Life360 (LIF) shares does Chris Hulls own after these transactions?

After the reported transactions, Chris Hulls directly holds 334,319 shares of Life360 common stock. The filing also reports indirect holdings through several 2023 irrevocable trusts, and notes that 108,371 restricted stock units are included within his reported ownership position.

What Life360 (LIF) stock options did Chris Hulls exercise in this Form 4?

Hulls exercised a fully vested stock option covering 27,000 shares of Life360 common stock. The option had an exercise price of $8.19 per share and an expiration date of May 20, 2028, and was reported as fully vested and exercisable in the filing.

Does the Form 4 mention Life360 (LIF) restricted stock units held by Chris Hulls?

Yes. The disclosure notes that Hulls’ reported holdings include 108,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Life360 common stock upon vesting, adding to his overall equity-based compensation exposure.